Condition: Critical Illness Myopathy · Guillain Barré Syndrome · Critical Illness Polyneuromyopathy (CIPNM) · Sponsor: Istituti Clinici Scientifici Maugeri SpA
The goal of this study is determine if a high-tech rehabilitation circuit is more effective than usual rehabilitation methods in improving functional outcome, particularly balance control, for patients with acute neuromuscolar diseases. The main question it aims to answer is: Are high-tech rehabilitation interventions, including robotic systems, virtual reality, and stabilometric platforms, more effective than traditional rehabilitation methods in improving balance, motor function, fatigue levels, sarcopenia, cognitive engagement, and overall quality of life in patients with acute neuromuscular diseases (NMDs)? Researchers will compare a robotic treatment group, that consists in an high-tech rehabilitation, with a control group, that will receive the traditional rehabilitative treatment.
This description comes directly from the study's public registry record.
Christian Lunetta, MD · +39 0250725266 · christian.lunetta@icsmaugeri.it
Always discuss trial participation with your own doctor first.
| Istituti Clinici Scientifici Maugeri | Bari, Italy | Not Yet Recruiting |
| IRCCS Azienda Ospedaliera Universitaria San Martino - Genova | Genova, Italy | Not Yet Recruiting |
| Istituti Clinici Scientifici Maugeri IRCCS, Milan Institute | Milan, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria di Modena | Modena, Italy | Not Yet Recruiting |
| Istituti Clinici Scientifici Maugeri | Montescano, Italy | Not Yet Recruiting |
| Istituti Clinici Scientifici Maugeri | Pavia, Italy | Not Yet Recruiting |
| Fondazione Don Carlo Gnocchi Onlus | Roma, Italy | Not Yet Recruiting |
| Istituti Clinici Scientifici Maugeri | Telese Terme, Italy | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06822231